Another study demonstrated that granulocyte colony-stimulating factor (G-CSF) treatment of BM leukemia stem cells (LSCs), which are responsible for leukemia initiation, relapse, and resistance to chemotherapy 9, significantly decreased the number of cells in the G0 phase and increased the number in the S and G2/M phase of the cell cycle. This evidence concerns the gene CSF3 and leukemia.